7.125% Fixed-Rate Reset Subordinated Debentures due 2052
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) Financial Performance & Income Statement Overview
Analyze 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) Income Statement & Financial Overview
Review 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 RZC income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.24M | $5.60B | $4.88B | $6.38B |
| Cost of Revenue | $0.00 | $299.00M | $301.00M | $283.00M |
| Gross Profit | $5.24M | $5.30B | $4.58B | $6.09B |
| Gross Profit Ratio | $1.00 | $0.95 | $0.94 | $0.96 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.54B | -$2.72B | $0.00 | $0.00 |
| Operating Expenses | $4.54B | -$1.36B | $4.54B | $670.00M |
| Total Costs & Expenses | $4.54B | -$1.06B | $4.54B | -$6.03B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $86000.00 | $78.00M | $72.00M | $68.00M |
| Depreciation & Amortization | $0.00 | $681.00M | -$341.00M | -$340.00M |
| EBITDA | $0.00 | $973.00M | -$73.00M | -$70.00M |
| EBITDA Ratio | $0.00 | $0.17 | -$0.01 | -$0.01 |
| Operating Income | -$4.54B | -$681.00M | $4.88B | $340.00M |
| Operating Income Ratio | -$865.67 | -$0.12 | $1.00 | $0.05 |
| Other Income/Expenses (Net) | $4.54B | $895.00M | -$4.61B | -$5.15B |
| Income Before Tax | $225000.00 | $214.00M | $269.00M | $272.00M |
| Income Before Tax Ratio | $0.04 | $0.04 | $0.06 | $0.04 |
| Income Tax Expense | $75000.00 | $56.00M | $65.00M | $60.00M |
| Net Income | $150000.00 | $161.00M | $203.00M | $210.00M |
| Net Income Ratio | $0.03 | $0.03 | $0.04 | $0.03 |
| EPS | -$8.57 | $2.40 | $3.03 | $3.18 |
| Diluted EPS | -$8.57 | $2.40 | $3.03 | $3.13 |
| Weighted Avg Shares Outstanding | $67.00M | $67.00M | $67.00M | $66.00M |
| Weighted Avg Shares Outstanding (Diluted) | $67.00M | $67.00M | $67.00M | $67.00M |
The company's financials show resilient growth, with revenue advancing from $6.38B in Q1 2024 to $5.24M in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 96% in Q1 2024. Operating income hit -$4.54B last quarter, sustaining a consistent -86567% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income dropped to $150000.00, while earnings per share reached -$8.57. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan